Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04007744
Title Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

pancreatic adenocarcinoma

transitional cell carcinoma

Advanced Solid Tumor

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma

melanoma

gastric adenocarcinoma

lung non-small cell carcinoma

Therapies

Pembrolizumab + Sonidegib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.